GlassScriptPhysician profile
Jay A Spinka
NPI 1548223134
$3,064.83
in general payments reported to CMS, 2019-2025
10 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $286 · 2023: $2,559 · 2024: $100 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,398 · Travel and Lodging: $1,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,397.60 |
| Travel and Lodging | $1,380.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,095.21 | 2023 | Journey II, Real Intelligence, Legion Revision |
| Pacira Pharmaceuticals Incorporated | $579.01 | 2023-2025 | Iovera, Exparel |
| Scilex Pharmaceuticals INC. | $81.08 | 2021 | |
| Vericel Corporation | $70.15 | 2024 | Maci |
| Collegium Pharmaceutical, INC. | $64.51 | 2021 | |
| Dynasplint Systems INC. | $64.20 | 2021 | |
| Allergan, INC. | $52.23 | 2021 | |
| Boston Scientific Corporation | $24.34 | 2021 | |
| Stryker Corporation | $18.52 | 2023 | Mako |
| Heraeus Medical, LLC. | $15.58 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Spinka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.